当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析 - 现金流量表

济川药业

(600566)

  

流通市值:402.56亿  总市值:405.23亿
流通股本:9.16亿   总股本:9.22亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金10,857,090,326.968,194,203,775.95,883,774,895.733,260,996,211.84
收到其他与经营活动有关的现金348,879,081.54489,248,835.42331,185,925.22135,630,907.7
经营活动现金流入的平衡项目0000
经营活动现金流入小计11,205,969,408.58,683,452,611.326,214,960,820.953,396,627,119.54
购买商品、接受劳务支付的现金1,306,098,753.54977,197,695.49623,506,836.77328,063,792.39
支付给职工以及为职工支付的现金868,293,968.94679,289,590.21483,679,040.12294,219,943.05
支付的各项税费1,649,967,405.331,161,530,630.12859,154,772.88481,292,588.77
支付其他与经营活动有关的现金3,917,650,644.863,005,795,553.422,050,089,634.97991,526,362.3
经营活动现金流出的平衡项目0000
经营活动现金流出小计7,742,010,772.675,823,813,469.244,016,430,284.742,095,102,686.51
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额3,463,958,635.832,859,639,142.082,198,530,536.211,301,524,433.03
二、投资活动产生的现金流量:
收回投资收到的现金4,653,315,385.943,957,703,350.262,632,940,661.41,371,000,000
取得投资收益收到的现金82,122,255.0475,411,044.6250,443,770.1328,252,760.95
处置固定资产、无形资产和其他长期资产收回的现金净额7,979,319.617,676,545.386,807,522.736,807,522.73
投资活动现金流入的平衡项目0000
投资活动现金流入小计4,743,416,960.594,040,790,940.262,690,191,954.261,406,060,283.68
购建固定资产、无形资产和其他长期资产支付的现金301,644,623.9238,163,197.62128,649,861.8154,982,057.67
投资支付的现金4,836,000,0003,396,098,2701,179,000,000-
投资活动现金流出的平衡项目0000
投资活动现金流出小计5,137,644,623.93,634,261,467.621,307,649,861.8154,982,057.67
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-394,227,663.31406,529,472.641,382,542,092.451,351,078,226.01
三、筹资活动产生的现金流量:
吸收投资收到的现金14,207,6002,983,6009,834,000-
取得借款收到的现金1,095,433,917.49603,513,258.78351,356,307.08-
筹资活动现金流入平衡项目000-
筹资活动现金流入小计1,109,641,517.49606,496,858.78361,190,307.08-
偿还债务支付的现金400,000,000201,867,396.05200,000,000-
分配股利、利润或偿付利息支付的现金823,189,505.03813,154,620.61317,282,472.973,784,465.88
支付其他与筹资活动有关的现金37,141,021.79555,756375,756-
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,260,330,526.821,015,577,772.66517,658,228.973,784,465.88
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-150,689,009.33-409,080,913.88-156,467,921.89-3,784,465.88
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额2,919,041,963.192,857,087,700.843,424,604,706.772,648,818,193.16
加:期初现金及现金等价物余额4,818,940,846.894,818,940,846.894,818,940,846.894,818,940,846.89
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额7,737,982,810.087,676,028,547.738,243,545,553.667,467,759,040.05
补充资料:
净利润2,827,062,991.25-1,342,057,774.06-
固定资产和投资性房地产折旧276,957,972.05-141,325,337.62-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧276,957,972.05-141,325,337.62-
无形资产摊销24,241,125.35-11,938,274.04-
长期待摊费用摊销2,042,299.31-1,149,555.81-
处置固定资产、无形资产和其他长期资产的损失-130,280.19--93,330.43-
固定资产报废损失1,089,302.99-236,689.59-
公允价值变动损失-14,603,985.81--20,903,837.88-
财务费用17,583,918.49-6,556,973.41-
投资损失-81,723,599.77--51,332,101.14-
递延所得税3,943,213.79-27,209,121.13-
其中:递延所得税资产减少16,713,849.7-15,633,035.34-
递延所得税负债增加-12,770,635.91-11,576,085.79-
存货的减少-98,601,442.43--139,696,761.99-
经营性应收项目的减少22,814,700.6-719,372,589.62-
经营性应付项目的增加476,510,317.56-193,310,236.28-
其他8,517,013.07-3,199,886.06-
现金的期末余额7,737,982,810.08-8,243,545,553.66-
减:现金的期初余额4,818,940,846.89-4,818,940,846.89-
公告日期2024-04-102023-10-232023-08-142023-04-18
审计意见(境内)标准无保留意见
TOP↑